The findings, which were part of a larger review commissioned by the World Health Organisation, suggested there was "no ...

Hormone replacement therapy (HRT) does not increase breast cancer risk in BRCA1/BRCA2 carriers, with estrogen-alone formulations showing a lower risk. The study used a matched-pair design to control ...

A major review of prior research has found no evidence that menopause hormone therapy either increases or decreases dementia ...

The findings show no evidence to suggest that hormone replacement therapy (HRT) either increases or decreases dementia risk ...

In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.

New study reveals effects of HRT on dementia risk - Research has been done to look into potential links between HRT and the ...

Many doctors agree with the Food and Drug Administration’s recent decision to remove the black box warnings on at least some ...

Hormone replacement therapy (HRT) has been linked to an increase in heart disease and blood clots in a study. The number of women using the treatment in England has surged to about 2.6 million. It ...

Women who use hormone replacement therapy (HRT) for at least a decade before their final period may see a reduced risk of breast cancer, heart attacks, or strokes, according to a new analysis.

HRT does not increase breast cancer risk in BRCA1/BRCA2 variant carriers, with lower incidence in users versus non-users. Estrogen-alone therapy is linked to reduced mortality, while estrogen plus ...

Menopause represents a profound systemic shift involving cardiovascular, skeletal, and neurological health, requiring ...